212-Pb/212-Bi-melanoma therapeutics (University of Missouri)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name212-Pb/212-Bi-melanoma therapeutics (University of Missouri)
Drug Alias Namelead-212/bismuth-212-melanoma therapeutics (University of Missouri)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetastasis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasm MetastasisMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Missouri
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Missouri
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisMelanoma

Other Information

ATC CodeN/A
Related LinksN/A